Drospirenon-soderzhashchie kontratseptivnye sredstva - vozmozhnosti rasshiryayutsya
- Autores: Prilepskaya V.N1, Novikova E.P1
-
Afiliações:
- Edição: Nº 12 (2012)
- Páginas: 49-52
- Seção: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/279701
- ID: 279701
Citar
Texto integral
Acesso aberto
Acesso está concedido
Acesso é pago ou somente para assinantes
Resumo
The article highlights the main benefits of combined oral contraceptives containing drospirenone, a gestagen of last generation. The results of numerous studies of foreign and domestic authors are presented. Particularly, the therapeutic potentials of drospirenone-containing drugs are discussed.
Palavras-chave
Texto integral
Sobre autores
V. Prilepskaya
Email: vprilepskaya@mail.ru
E. Novikova
Email: taukita.matsuda@gmail.com
Bibliografia
- Руководство по контрацепции / Под ред. В. Н. Прилепской. М., 2006. 400 с.
- Wiegratz I, Kuhl H. Metabolic and clinical effects of progestogens. Eur J Contracept Reprod Health Care 2006;11:153-61.
- Van Vloten WA, van Haselen CW, van Zuuren EJ, et al. The effect of 2 combined oral Contraceptives containing either drospirenone or cyproterone acetate on acne and seborrhea. Cutis 2002;69(4):2-15.
- The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report Task Force on the Phenotype of the Polycystic Ovary Syndrome of The Androgen Excess and PCOS Society. Fertil Steril 2009;91:456-88.
- Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society. J Clin Endocrin Metab 2010: 2009-724.
- Marr J, Heinemann K, Kunz M, Rapkin A. Ethinyl estradiol 20 g/drospirenone 3mg 24/4 oral contraceptive for the treatment of functional impairment in women with premenstrual dysphoric disorder. Int J Gynaecol Obstet 2011;113(2):103-07.
- Paul G, Bell C. The real deal: A feasibility study of peer-led sex education for early school leavers. Contraception Reproductive Health Care 2010;5(5):343-57.
- Motivala A, Pitt B. Drospirenone fore Oral Contraception and Hormone Replacement Therapy. Drugs 2007;7(5):647-55.
- Feldmann. Gynaecol 2006;27;157-59.
- Геворкян М.А., Манухин И.Б., Тихомиров А.Л., Кузнецова Е.М. Опыт применения дроспиренон-содержащего гормонального контрацептива // РМЖ: Мать и дитя. Акушерство и гинекология 2011. № 1.
Arquivos suplementares
